Silo Pharma Inc (SILO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 18 | 18 | 18 | 18 | 18 |
| Cost of Goods | 2 | 2 | 2 | 2 | 2 |
| Gross Profit | 17 | 17 | 17 | 17 | 17 |
| Operating Expenses | 1,831 | 1,028 | 1,021 | 898 | 1,182 |
| Operating Income | -1,813 | -1,010 | -1,003 | -880 | -1,164 |
| Interest Expense | 0 | 1 | 2 | 2 | 0 |
| Other Income | 83 | 82 | 73 | 80 | 112 |
| Pre-tax Income | -1,731 | -929 | -932 | -802 | -1,052 |
| Net Income Continuous | -1,731 | -929 | -932 | -802 | -1,052 |
| Net Income | $-1,731 | $-929 | $-932 | $-802 | $-1,121 |
| EPS Basic Total Ops | -0.38 | -0.22 | -0.31 | -0.28 | -0.38 |
| EPS Basic Continuous Ops | -0.39 | -0.22 | -0.31 | -0.28 | -0.36 |
| EPS Diluted Total Ops | -0.38 | -0.22 | -0.31 | -0.28 | -0.38 |
| EPS Diluted Continuous Ops | -0.39 | -0.22 | -0.31 | -0.28 | -0.36 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.22 | -0.31 | -0.28 | N/A |
| EBITDA(a) | $-1,810 | $-1,010 | $-1,003 | $-880 | $-1,164 |